The addition of itacitinib to standard graft-versus-host-disease prophylaxis may reduce severe toxicities following ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback